from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0008c/-

LFCtreatmentdescriptionclass of inhibitor

0.865

Amikacinug/mL Amikacintranslation

2.056

Cap5-10ug/mL Capreomycintranslation

1.569

Rox10-50 ug/mL Roxithromycintranslation

-0.066

SM2-5 ug/mL Streptomycintranslation

1.477

Tet5-10 ug/mL Tetracyclinetranslation

-0.594

Rif0.2-5ug/mL Rifampicintranscription

0.707

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.194

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.381

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.504

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.483

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.641

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.494

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.187

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.612

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.610

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.668

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.680

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.711

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.154

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.655

KCN5-20 ug/mL Potassium cyaniderespiration

-1.028

NaN30.2-2 mM Sodium aziderespiration

0.201

Nigericin50 uM Nigericinrespiration

-0.276

TRC10-150 ug/mL Triclosanrespiration

0.470

TRZ10-25 ug/mL Thioridazinerespiration

1.483

Valinomycin0.5-10 uM Valinomycinrespiration

-0.567

ZnSO42 mM ZnSO4respiration

-0.196

menadione6-10 ug/mL Menadionerespiration

-0.185

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.158

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.566

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.080

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.974

NRP_1Non-replicating persistence stage 1dosRassociated

0.274

Amp0.2mg/mL AmpicillincellWall

0.194

Cephalexin20-100 ug/mL CephalexincellWall

0.736

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.682

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.179

EMB10-20 ug/mL EthambutolcellWall

0.076

Eta12-40 ug/mL EthionamidecellWall

-0.244

INH0.2-0.4 ug/mL IsoniazidcellWall

0.173

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.784

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.046

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.042

BZA0.12 mg/mL BenzamidearomaticAmides

0.422

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.276

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.913

H2O24 mM hydrogen peroxideDNAdamaging

0.394

Levo10 ug/mL LevofloxacinDNAdamaging

0.527

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.570

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.027

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.402

UVUV-irradiationDNAdamaging

0.361

ARP41-4 ug/mL Antitubercular compound ARP4?

0.076

Antimycin12.5-50 ug/mL Antimycin A?

-0.240

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.567

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.022

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.088

PA8240.2-2 ug/mL PA-824?

-1.308

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.088

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.078

Verapamil50 uM Verapamil?

-0.050

mercaptoethanol2 mM 2-Mercaptoethanol?

0.152

methoxatin10-20 ug/mL Methoxatin?